"10.1371_journal.pone.0128632","plos one","2015-06-22T00:00:00Z","Jung Nam An; Jin Ho Hwang; Jung Pyo Lee; Ho Jun Chin; Sejoong Kim; Dong Ki Kim; Suhnggwon Kim; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Chun Soo Lim","Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea; Department of Internal Medicine, Seoul National University Bundang Hospital, Seong-Nam, Korea; Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea; Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea; Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea; Department of Internal Medicine, Seoul St. Marys Hospital, Seoul, Korea","Conceived and designed the experiments: Suhnggwon Kim HJC CSL. Performed the experiments: JNA JHH HJC Sejoong Kim DKK JHP SJS SHL BSC CSL. Analyzed the data: JNA JHH JPL CSL. Contributed reagents/materials/analysis tools: JNA JHH JPL HJC CSL. Wrote the paper: JNA JHH JPL HJC CSL. Statistical analysis: JNA JHH JPL CSL. Supervision or mentorship: CSL. Contributed important intellectual content during manuscript drafting or revision, and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved: JNA JHH JPL HJC Sejoong Kim DKK Suhnggwon Kim JHP SJS SHL BSC CSL. Takes responsibility that this study has been reported honestly, accurately, and transparently; that no important aspects of the study have been omitted, and that any discrepancies from the study as planned have been explained: CSL.","This study was funded by Daiichi Sankyo Korea Co. Ltd., and Daewoong Pharmaceutical Co. Ltd., Seoul, Korea. Olmesartan medoxomil was also provided by the same pharmaceutical companies for all participants. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","06","Jung Nam An","JNA",12,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
